Obstructive sleep apnea in chronic obstructive pulmonary disease patients

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 2, 2011, Pages 79-83

  Lee, Ruth ^a   McNicholas, Walter T ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

cardiovascular disease; chronic obstructive pulmonary disease; hypoxia; obstructive sleep apnea; systemic inflammation

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BREATHING; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FORCED EXPIRATORY VOLUME; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; HYPERCAPNIA; HYPERINFLATION; HYPOXEMIA; INSPIRATORY CAPACITY; LONG TERM CARE; LUNG CAPACITY; MORBIDITY; OBESITY; OXIDATIVE STRESS; OXYGEN SATURATION; OXYGEN THERAPY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; REM SLEEP; RESPIRATORY TRACT DISEASE; SEPSIS; SLEEP APNEA SYNDROME; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION;

ANOXIA; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; HYPERCAPNIA; INFLAMMATION; OXIDATIVE STRESS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP APNEA, OBSTRUCTIVE; SYNDROME;

EID: 79951677941     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834317bb     Document Type: Article

References (45)

1. Collop N. Sleep and sleep disorders in chronic obstructive pulmonary disease. Respiration 2010; 80:78-86.
2. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 2009; 180:692-700.
3. Shteinberg M, Weiler-Ravel D, Adir Y. The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease. Harefuah 2009; 148:333-336.
4. Chaouat A, Weitzenbum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151:82-86.
5. Sanders MH, Newman AB, Haggerty CL, et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003; 167:7-14. (Pubitemid 36018746)
6. López-Acevedo M, Torres-Palacios A, Elena Ocasio-Tascón M, et al. Overlap syndrome: an indication for sleep studies? Sleep Breath 2009, 13: 409-413.
7. Celli B, Halbert R, Isonaka S, et al. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22:268-273. (Pubitemid 36986996)
8. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239. (Pubitemid 34461732)
9. Marin JM, Soriano JB, Carrizo SJ, et al. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182:325-331.
10. Toraldo D, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath 2010; 14:115-123.
11. Machado MCL, Vollmer WM, Togeiro SM, et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010; 35:132-137.
12. Tsai SC, Lee-Chiong T. Lung hyperinflation and sleep quality in the overlap syndrome. COPD 2009; 6:419-420.
13. Kwon JS, Wolfe LF, Lu BS, et al. Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. COPD 2009; 6:441-445.
14. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
15. Wouters E. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:26-33. (Pubitemid 40562960)
16. Ryan S, Taylor CT, McNicholas WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009; 64:631-636.
17. MacNee W, Maclay J, McAllister D. Cardiovascular injury and repair in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:824-833.
18. Savransky V, Nanayakkara A, Li J, et al. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007; 175:1290-1297. (Pubitemid 46905755)
19. Laffey JG, Tanaka M, Engelberts D, et al. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000; 162:2287-2294. (Pubitemid 32051702)
20. Kimura D, Totapally BR, Raszynski A, et al. The effects of CO2 on cytokine concentrations in endotoxin-stimulated human whole blood. Crit Care Med 2008; 36:2823-2827.
21. Agust A, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21: 347-360 [review]. (Pubitemid 36204553)
22. Fabbri LM, Luppi F, Beghe B, et al. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-212.
23. McNicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29:156-178. (Pubitemid 46092013)
24. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112:2660-2667. (Pubitemid 41532603)
25. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003; 7:35-51. (Pubitemid 36188305)
26. Redolfi S, Yumino D, Ruttanaumpawan P, et al. Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009; 179:241-246.
27. Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. Can Med Assoc J 2006; 174:1293-1299.
28. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnoea. Eur Respir J 1995; 8:1161-1178.
29. Mulloy E, McNicholas WT. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148:1030-1036. (Pubitemid 23301226)
30. Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A doubleblind evaluation. Chest 1992; 101:753-757.
31. McNicholas WT, Calverley PMA, Lee A, et al. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 2004; 23:825-831. (Pubitemid 38807354)
32. Ryan S, Doherty LS, Rock C, et al. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 2010; 79:475-481.
33. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107:1129-1134. (Pubitemid 36297204)
34. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250-255. (Pubitemid 46203128)
35. Ryan S, Nolan G, Hannigan E, et al. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 2007; 62:509-514. (Pubitemid 46910129)
36. Eid A, Ionescu A, Nixon L, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1414-1418. (Pubitemid 33124019)
37. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1179-1184. (Pubitemid 30243827)
38. Ryan S, Taylor C, McNicholas W. Predictors of elevated nuclear factorkappaB- dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006; 174:824-830. (Pubitemid 44511665)
39. MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117:303S- 317S. (Pubitemid 30327005)
40. Hurst J, Perera W, Wilkinson T, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:71-78. (Pubitemid 43069790)
41. Chen L, Einbinder E, Zhang Q, et al. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 2005; 172:915-920. (Pubitemid 41369077)
42. Schulz R, Mahmoudi S, Hattar K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000; 162:566-570. (Pubitemid 30647201)
43. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007; 131:1557-1566. (Pubitemid 46762366)
44. Soriano JB, Yanez A, Renom F, et al. Set-up and pilot of a population cohort for the study of the natural history of COPD and OSA: the PULSAIB study. Prim Care Respir J 2010; 19:140-147.
45. Larsson LG, Lindberg A. Concomitant obstructive sleep apnea and chronic obstructive pulmonary disease: study design - the OLIN OSAS-COPD study. Clin Respir J 2008; 2 (Suppl 1):120-122.